LA JOLLA, Calif.--(BUSINESS WIRE)--Dec. 5, 2005--Stratagene Corporation (NASDAQ:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostic products, announced today that it has entered into a License, Manufacturing and Supply Agreement with privately-held Focus Diagnostics, Inc. to address the growing molecular diagnostics market for infectious diseases. Focus Diagnostics, of Herndon, Virginia, is a specialty diagnostics company that develops innovative infectious disease products and is a leading reference laboratory for infectious and immunological diseases.
